Putnam Investments’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-68,603
Closed -$4.41M 920
2020
Q1
$4.41M Buy
68,603
+17,189
+33% +$1.2M 0.01% 462
2019
Q4
$3.06M Hold
51,414
0.01% 647
2019
Q3
$3.03M Buy
51,414
+9,268
+22% +$592K 0.01% 627
2019
Q2
$2.72M Buy
42,146
+7,829
+23% +$505K 0.01% 677
2019
Q1
$2.18M Buy
+34,317
New +$1.8M 0.01% 686

Other funds holding TNDM

Putnam Investments's TNDM Position: Q2 2020 in Review

Putnam Investments sold out of Tandem Diabetes Care (TNDM) in Q2 2020, closing a stake of 68,603 shares — an estimated $4.41M sold.

Putnam Investments first reported a position in TNDM in Q1 2019 and held it in 5 quarters. The position peaked at $4.41M in Q1 2020. 303 funds tracked by Wall St. Rank hold TNDM as of Q2 2020.

  • Putnam Investments reported no remaining Tandem Diabetes Care position as of Q2 2020 after selling out during the quarter.
  • Putnam Investments sold 68,603 Tandem Diabetes Care shares in Q2 2020, an estimated $4.41M.
  • Putnam Investments first reported a position in Tandem Diabetes Care in Q1 2019 and held it in 5 quarters.
  • Putnam Investments's Tandem Diabetes Care position peaked at $4.41M in Q1 2020.
  • 303 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2020.

Based on Putnam Investments's 13F filing for Q2 2020, filed 14 Aug 2020.